XBiotech Competitors and Similar CompaniesClear all
XBiotech's competitors and similar companies include Aptinyx and RAPT Therapeutics.
 XBiotech XBiotech is a biosciences company dedicated to the discovery, development, and commercialization of therapeutic antibodies based on its True Human technology.
|  Aptinyx Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | |
Founding Date | Founding Date 2005 | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Austin, US HQ | Locations Evanston, US HQ Evanston, US | Locations South San Francisco, US HQ |
Employees | Employees 8510% decrease | Employees 635% increase | Employees 64 |
Valuation ($) | Valuation ($) 234.4 m | Valuation ($) 4.1 m | Valuation ($) 69.8 m |
Financial | |||
Net income | Net income ($45.5m) (FY, 2025) | Net income ($64.8m) (FY, 2022) | Net income ($129.9m) (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 135m | Total funding raised $ 176m |
For sources of this data, please see the company profile
View Company Profiles
Aptinyx
HQ
Evanston, US
Employees
63↑ 5% increase
Aptinyx is a clinical-stage biopharmaceutical company focused on the discovery and development of transformative therapies for challenging neurologic disorders.
View companyRAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company